Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.
Despite being an essential vitamin, folate has been implicated to enhance tumor growth, as evidenced by reports on overexpression of folate receptor alpha (FRα) in carcinomas. The role of another folate transporter, reduced folate carrier (RFC), is largely unknown. This study investigated the roles...
Saved in:
Main Authors: | Michelle K Y Siu, Daniel S H Kong, Hoi Yan Chan, Esther S Y Wong, Philip P C Ip, LiLi Jiang, Hextan Y S Ngan, Xiao-Feng Le, Annie N Y Cheung |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/40c416e45d574a99bedf8a7ff451949c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
by: Jiangnan He, et al.
Published: (2021) -
Regulation of PCNA cycling on replicating DNA by RFC and RFC-like complexes
by: Mi-Sun Kang, et al.
Published: (2019) -
Increased expression of PITX2 transcription factor contributes to ovarian cancer progression.
by: Frederic K C Fung, et al.
Published: (2012) -
Polymorphisms in MTHFR, MTR, RFC1 and CßS genes involved in folate metabolism and thyroid cancer: a case-control study
by: Tairine Zara-Lopes, et al.
Published: (2019) -
IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer
by: Song J, et al.
Published: (2019)